Asarfi Hospital
- Market cap
- ₹ 334 Cr.
- P/E
- 18.4x
- P/B
- 3.62x
- 52-week range
- 135 – 256.95
- ROE
- 19%
- ROCE
- 19%
- Dividend yield
- 0%
- Debt / equity
- 0.59
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- BSE SME
About
Asarfi Hospital Limited is an India-based super specialty hospital company. The Company provides treatment to people requiring medical attention and primary health services and provides different preventive healthcare services, including vaccination center, drug distribution center also run health awareness program, hygiene awareness program, health camp, health education center, yoga center, exercise center, health resort, health information center and others. It operates a 250 bedded multi-specialty hospital that offers advanced medical care and emergency services. The Hospital has a full-fledged High Dependency Unit, Emergency Department, Outpatient consultation, CCU, ICU, NICU, SICU, Labor Room, Endoscopy Room, Neurosurgery and Cardiac unit equipped with Phillips FD10 flat panel CATHLAB with Stent Boost. The Diagnostic Center features advanced laboratory and imaging equipment like Open X-Ray, Ultrasound, CT scan. The Hospital offers both inpatient and outpatient care.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Asarfi Hospital against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)18.4 against a typical 48.9: cheaper than most peers (1st = cheapest).5th of 40
- Sales growth+32.8% against a typical +21.1% from a year earlier.11th of 34
- Profit growth+33.4% against a typical +13% from a year earlier.11th of 31
- Share price, 3 months−23.9% against a typical −8.8%.31st of 35
- Size₹ 334.3 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).22nd of 36
Research by Minerva Capital Research Solutions
Our research team's work on Asarfi HospitalAlso covered in
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20 | 24 | 31 | 33 | 35 | 36 | 45 | 46 | 45 | 47 |
| Expenses | 16 | 20 | 24 | 26 | 29 | 29 | 36 | 36 | 37 | 38 |
| Operating Profit | 4 | 4 | 7 | 7 | 6 | 7 | 9 | 10 | 8 | 9 |
| OPM % | 20% | 16.6% | 22% | 21.3% | 18.4% | 19.7% | 19.9% | 22% | 17.5% | 19.9% |
| Other Income | 1 | −0 | 1 | 1 | 4 | 1 | 1 | 2 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 1 | −1 | 4 | 4 | 6 | 4 | 6 | 8 | 5 | 6 |
| Tax % | 102.9% | −76.1% | 27.1% | 25.4% | 30.9% | 25.3% | 25.2% | 27.1% | 19.5% | 25.2% |
| Net Profit | −0 | −0 | 3 | 3 | 4 | 3 | 4 | 5 | 4 | 4 |
| EPS in Rs | −0.03 | −0.08 | 1.47 | 1.38 | 1.95 | 1.63 | 2.19 | 2.78 | 2.08 | 2.17 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 26%
- 3 Years
- 36%
- TTM
- 36%
- 10 Years
- —
- 5 Years
- 37%
- 3 Years
- 29%
- TTM
- 43%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 22%
- TTM
- —
- 10 Years
- —
- 5 Years
- 17%
- 3 Years
- 14%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Asarfi Hospital | ₹ 160.00 | ₹ 334 Cr. | 18.4x | 3.6x | 19% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Harendra Singh
- Chief Executive Officer, Chief Financial Officer
- Sudipa Singh
- Company Secretary and Compliance Officer
- Udai Pratap Singh
- Managing Director, Executive Director
- Madhuri Singh
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.